Rajesh Ranadive
Internal Medicine · Petaluma, CANPI 1497704522
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by Amgen at 24.1% of the total. Reporting peaked in 2019 at $681 and has fallen 82.8% since, to $117 in 2025.
Across 98 payments — averaging $20.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$489
- Novo Nordisk$269
- Pfizer$180
- Radius Health, Inc.$125
- Vertex$103
- Boehringer Ingelheim$102
- plus $764 from 23 others
What the payments were for
- Consulting fees$201%
- Food & beverage$2,00299%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 26 | $489 |
| Novo Nordisk | 14 | $269 |
| Pfizer | 10 | $180 |
| Radius Health, Inc. | 1 | $125 |
| Vertex | 1 | $103 |
| Boehringer Ingelheim | 5 | $102 |
| Merck | 5 | $96 |
| AbbVie(2 entities) | 5 | $86 |
| Insulet Corporation | 3 | $51 |
| Edwards Lifesciences | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Biogen | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Sanofi-aventis U.S. LLC | 2 | $39 |
| Sanofi Pasteur Inc. | 2 | $36 |
| AstraZeneca | 2 | $35 |
| Johnson & Johnson | 2 | $30 |
| Boston Scientific | 1 | $27 |
| Lilly USA, LLC | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $18 |
| Cook Medical LLC | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Advanced Oxygen Therapy Inc. | 1 | $15 |
| GSK | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
| Scilex Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,031 in reported general payments places this provider in the 80th percentile of 13,581 internal medicine providers in California.
Other internal medicine in Petaluma
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Hatim HusainSan Diego$2M
- Teck LingPalo Alto$1.1M
- Hyong Kimla Jolla$1M
- Rohit Loombala Jolla$965K
- Fred CohenSan Francisco$929K
- Steven EdelmanSan Diego$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.